Outlook for HL RX

2021 was a relatively slow year for RX and I’m wondering about HL RX’s outlook & also RX in general (given the global economic recovery but inevitably hawkish monetary policy)

i feel like the RX space is becoming more crowded (e.g. EVR MOE LAZ PJT + many other solid firms) - was speaking to an MD and he mentioned that apparently two decades ago there weren’t as many players competing in the RX space

saw a few similar posts and thought I’d throw this one out there

4 Comments
 
Most Helpful

Two decades ago there weren't as many players competing in the traditional IBD space either.  Corporate defaults are at historic lows right now but are expected to start picking up again on the back half of this year.  Still, top groups maintain deal flow even if it's not as insane as 2020 which you wouldn't want anyways if you were working in industry because that was just unsustainable from a staffing perspective.  Top RX groups will always have deal flow.

 

that’s a good point, advisory has grown significantly over the last 2 decades

i think also in europe/uk the legal system is evolving to become more similar to a “Chapter 11 lite” framework - thus opening the doors to a lot more complex rx situations and potentially DIP financing down the line

any insights on how the different rx shops will grow in next 2-5 years? PJT seems to be becoming lot stronger since it’s BX days

 

Molestiae at delectus accusantium repellendus. Corrupti quos eum omnis mollitia nulla quas. Ut perferendis et ratione qui perspiciatis laborum.

Velit doloremque incidunt autem. Nobis tempora autem ea. Quibusdam consequatur est quibusdam magni.

Illum maxime voluptatibus illo qui libero. Repellendus esse quos commodi corporis minus impedit assumenda. Omnis nesciunt ipsum nostrum libero impedit. Incidunt laboriosam ducimus sit assumenda quod consequatur. Quia aperiam rerum nulla sunt libero nemo autem vel. Et non est omnis blanditiis aliquid. Nulla aliquid qui incidunt doloribus.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Morgan Stanley 02 98.8%
  • Evercore 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan No 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (45) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
CompBanker's picture
CompBanker
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
DrApeman's picture
DrApeman
98.9
8
dosk17's picture
dosk17
98.9
9
GameTheory's picture
GameTheory
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”